National Quality Measures Clearinghouse | Pancreatic cancer: American College of Surgeons

American College of Surgeons

• Pancreatic cancer: does the institution that performs pancreatic cancer surgery have an intensive care unit staffed by critical care specialists?

• Pancreatic cancer: does the institution that performs pancreatic cancer surgery have interventional radiology services available on site?

• Pancreatic cancer: does the institution that performs pancreatic cancer surgery monitor their average annual case volume?

• Pancreatic cancer: does the institution that performs pancreatic cancer surgery monitor their surgeons' annual case volume?

• Pancreatic cancer: does the institution that performs resection ensure that their surgeons are certified by the American Board of Surgery or equivalent international organization?

• Pancreatic cancer: does the institution that performs resection for pancreatic cancer treat their patients in a multidisciplinary effort with a surgeon, medical oncologist, and a radiation oncologist?

• Pancreatic cancer: percentage of patients being considered for resection for whom a triple-phase, multi-slice CT or MRI scan is obtained.

• Pancreatic cancer: percentage of patients diagnosed with pancreatic cancer for whom a stage-specific treatment plan is documented.

• Pancreatic cancer: percentage of patients that undergo resection for whom a history and physical with thorough preoperative risk assessment is performed.

• Pancreatic cancer: percentage of patients undergoing a cancer-directed resection for whom a clinical and pathologic stage is recorded.

• Pancreatic cancer: percentage of patients undergoing adjuvant therapy for whom the timing relative to resection (before, after, both) is recorded.

• Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the margin status is recorded.

• Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the number of lymph nodes examined is recorded.

• Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the number of lymph nodes positive is recorded.

• Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the tumor grade is recorded.

• Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the tumor histology is recorded.

• Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the tumor size is recorded.

• Pancreatic cancer: percentage of patients undergoing resection for whom suspicious adenopathy outside the scope of planned resection is evaluated by frozen section.

• Pancreatic cancer: percentage of patients undergoing resection for whom the College of American Pathologists checklist or equivalent reporting system is followed and fully documented.

• Pancreatic cancer: percentage of patients undergoing resection of a pancreatic head lesion for whom the surgeon documents complete removal of all pancreatic tissue, lymph nodes, and connective tissue between the edge of the uncinate process and the right lateral wall of the superior mesenteric artery in the operative note.

• Pancreatic cancer: percentage of patients who do not undergo resection for whom a TNM clinical stage is recorded.

• Pancreatic cancer: percentage of patients who undergo resection for pancreatic cancer who are treated in a multidisciplinary effort with a surgeon, medical oncologist, and a radiation oncologist.

Pancreatic cancer: percentage of patients who undergo resection for whom the hospital has ensured that the surgeon is certified by the American Board of Surgery or equivalent international organization.